text.skipToContent text.skipToNavigation
+48 22 751 31 40

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?
{{requestQuote.productName}}; {{requestQuote.form.productCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

 Bulk Order
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
Popular Regions
All Regions
+48 22 751 31 40

Lopinavir

Product Code

TRC-L469480

CAS Number

192725-17-0

Product Format

Neat

Molecular Formula

C37 H48 N4 O5

Molecular Weight

628.80

API Family

Lopinavir

Product Categories

TRC, Chiral Molecules , Antivirals and antiretrovirals, Antivirals, Enzyme inhibitors, API Reference Standards & Research Materials, Antivirals and antiretrovirals, Anti-HIV agents, Antivirals and antiretrovirals, Protein kinases, Pain and Inflammation, Pharmaceutical and Veterinary Residue Reference Materials , Pharmaceutical, Veterinary Compound & Metabolite Reference Materials , Pharmaceutical Toxicology Reference Materials

Product Type

API

Price and availability

48-hour USA dispatch time
If Exact Weight packaging is selected, a certificate will be delivered with the product, which will indicate the mass of the material dispensed into the vial with a precision of up to 3 decimal places. Exceptions apply.
Request custom pack size quote

{{ favouriteItem.successMessage }}

View favourites

Product removed from your favourites

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?
{{requestQuote.productName}}; {{requestQuote.form.productCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

Documentation

Where shall we send your requested CoA?
Part number:  {{ coaPopupData.packSize.code }}

{{ errors.first('lotNumber') }}

{{ errors.first('requestEmail') }}
LGC will use your email address only for the purposes of providing the requested document.
For information about our data processing activities, please visit our Privacy Notice.

{{ coaPopupData.serverError }}
Where shall we send your requested CoA?

Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}

{{ errors.first('coaEmail') }}

 By entering your email address, you confirm that you give your consent to LGC to share information in connection with the product(s) above and other similar products from time to time. LGC will process your personal data in accordance with all applicable data protection rules and regulations. For information relating to LGC’s data processing activities, please visit our Privacy Policy below (see footer).
Cancel
Thank you

We will be sending the CoA to your email address  {{ coaEmailPopupData.userEmail }}

Thank you

Your request has been sent to our sales team to process.
Where shall we send your requested SDS?
Part number:  {{ sdsPopupData.packSize.code }}

{{ errors.first('selectedRegion') }}

{{ errors.first('sdsEmail') }}

LGC will use your email address only for the purposes of providing the requested document.
For information about our data processing activities, please visit our Privacy Notice.

{{ sdsPopupData.serverError }}
Thank you

Your request has been sent to our sales team to process.

Product Information

Product Notes

Lopinavir is an antiretroviral and selective HIV-1 protease inhibitor, used as a treatment for HIV-1 in combination with other antiretrovirals due to its poor bioavailability. An analogue of Ritonavir, it is a peptidomometic molecule that mimics the peptide linkage typically targeted by HIV-1 protease enzymes. Lopinavir is found to inhibit MERS-CoV replication in the low-micromolar range in cell cultures. Lopinavir with Ritonavir is currently being investigated as a potential drug target for the treatment of COVID-19. 
References

[1] Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998).
[2] Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999).
[3]Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999).
[4]Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382(19):1787-1799. doi:10.1056/NEJMoa2001282.
[5]Chan JF, Yao Y, Yeung ML, et al. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015;212(12):1904-1913. doi:10.1093/infdis/jiv392.
[6]Corrao S, Natoli G, Cacopardo B. A Trial of Lopinavir-Ritonavir in Covid-19. N Engl J Med. 2020;382(21):e68. doi:10.1056/NEJMc2008043.

Chemical Data

Analyte Name

Lopinavir

CAS Number

192725-17-0

Molecular Formula

C37 H48 N4 O5

Molecular Weight

628.80

Accurate Mass

628.3625

SMILES

CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)Cc4ccccc4

InChI

InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1

IUPAC

(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide

Product Data

Storage Temperature

-20°C

Shipping Temperature

Room Temperature

Country of Origin

CANADA

Product Type

API

Product Format

Neat

API Family

Lopinavir

Punchout session timeout warning

Your punchout session will expire in1 min59 sec.

Select "Continue session" to extend your session.